ArticleBMC cancer2026

Bridging the evidence gap in trial inclusion with real world safety profile assessment in relapsed/refractory multiple myeloma patients.

Rana Jreich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.